PuSH - Publication Server of Helmholtz Zentrum München

Tian, X.* ; Li, R.* ; Jiang, Y. ; Zhao, F.* ; Yu, Z.* ; Wang, Y.* ; Dong, Z.* ; Liu, P.* ; Li, X.*

Bifidobacterium breve ATCC15700 pretreatment prevents alcoholic liver disease through modulating gut microbiota in mice exposed to chronic alcohol intake.

J. Funct. Food. 72:104045 (2020)
Publ. Version/Full Text Research data DOI
Open Access Hybrid
Creative Commons Lizenzvertrag
Gut microbiota has been identified as a key player in the development of alcoholic liver disease (ALD). Targeting gut microbiota with probiotic intervention will be an attractive approach to prevent ALD. Here, we investigated the effects of probiotic Bifidobacterium breve ATCC15700 (ATCC15700) on liver injury and gut microbiota in mice exposed to chronic alcohol intake. Our results showed that oral administration of ATCC15700 significantly decreased endotoxemia, maintained immune homeostasis, and alleviated alcohol-induced liver injury. ATCC15700 also promoted intestinal barrier function by enhancing the expressions of tight junction proteins in alcohol-treated mice. Moreover, analysis of gut microbiota showed that ATCC15700 normalized the structure and composition of the alcohol-disrupted gut microbiota. Correlation between gut microbiota and liver injury parameters revealed that specific bacteria, including S24_7, unclassified Clostridiales, Butyricicoccus, Oscillospira, Ruminococcus, Mucispirillum and unclassified Lachnospiraceae, were predominantly associated with ALD. In conclusion, ATCC15700 protected alcohol-exposed mice against liver injury via modulating gut micobiota.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
3.701
1.235
6
10
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Bifidobacterium Breve Atcc15700 ; Alcoholic Liver Disease ; Immune Homeostasis ; Inflammation ; Intestinal Barrier Function ; Gut Microbiota; Intestinal Permeability; Aldehyde Dehydrogenase; Mouse Model; Injury; Dysbiosis; Inflammation; Protection; Dependence; Probiotics; Enzymes
Language english
Publication Year 2020
HGF-reported in Year 2020
ISSN (print) / ISBN 1756-4646
e-ISSN 1756-4646
Quellenangaben Volume: 72, Issue: , Pages: , Article Number: 104045 Supplement: ,
Publisher Elsevier
Publishing Place Amsterdam
Reviewing status Peer reviewed
POF-Topic(s) 30203 - Molecular Targets and Therapies
Research field(s) Immune Response and Infection
PSP Element(s) G-554300-001
Scopus ID 85087083826
Erfassungsdatum 2020-07-21